Discovering a new world of therapeutics

The therapeutic potential of the human transcriptome, the set of all RNAs transcribed from DNA, remains largely unexplored. By harnessing new insights into RNA structure and dynamics, Arrakis is opening the transcriptome to therapy by small-molecule medicines to treat patients not cured by today’s medicines. We aim to unlock the therapeutic potential of deeply researched, valuable targets and to identify new disease intervention points that may be uniquely addressed with RNA-targeted small molecules.

RNA Dynamics – A Bug or a Feature?
Feb 14, 2018
Donovan Chin
 
The prospect of RNA targeting using small molecules
Dec 13, 2017
David Chenoweth, PhD
 
Why NOW for Targeting RNA with Small Molecules?
Nov 28, 2017
Russ Petter, PhD
 
Back to Top